Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1588447875;47876;47877 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
N2AB1424342952;42953;42954 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
N2A1331640171;40172;40173 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
N2B681920680;20681;20682 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
Novex-1694421055;21056;21057 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
Novex-2701121256;21257;21258 chr2:178617435;178617434;178617433chr2:179482162;179482161;179482160
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Fn3-3
  • Domain position: 26
  • Structural Position: 28
  • Q(SASA): 0.6366
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P rs1167024702 -0.051 1.0 N 0.707 0.572 0.587751488883 gnomAD-2.1.1 8.74E-06 None None None None I None 0 0 None 0 0 None 0 None 9.47E-05 0 0
L/P rs1167024702 -0.051 1.0 N 0.707 0.572 0.587751488883 gnomAD-4.0.0 3.27201E-06 None None None None I None 0 0 None 0 0 None 3.78845E-05 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.2022 likely_benign 0.1972 benign -0.525 Destabilizing 0.999 D 0.66 neutral None None None None I
L/C 0.5763 likely_pathogenic 0.5584 ambiguous -0.645 Destabilizing 1.0 D 0.663 neutral None None None None I
L/D 0.5962 likely_pathogenic 0.5867 pathogenic -0.099 Destabilizing 1.0 D 0.704 prob.neutral None None None None I
L/E 0.238 likely_benign 0.2118 benign -0.192 Destabilizing 1.0 D 0.73 prob.delet. None None None None I
L/F 0.1911 likely_benign 0.2005 benign -0.565 Destabilizing 1.0 D 0.714 prob.delet. None None None None I
L/G 0.4529 ambiguous 0.4391 ambiguous -0.673 Destabilizing 1.0 D 0.732 prob.delet. None None None None I
L/H 0.3085 likely_benign 0.3026 benign 0.013 Stabilizing 1.0 D 0.723 prob.delet. None None None None I
L/I 0.0977 likely_benign 0.1062 benign -0.261 Destabilizing 0.999 D 0.555 neutral None None None None I
L/K 0.2275 likely_benign 0.1873 benign -0.303 Destabilizing 1.0 D 0.721 prob.delet. None None None None I
L/M 0.1284 likely_benign 0.1357 benign -0.402 Destabilizing 1.0 D 0.654 neutral N 0.468718115 None None I
L/N 0.3549 ambiguous 0.3528 ambiguous -0.119 Destabilizing 1.0 D 0.706 prob.neutral None None None None I
L/P 0.3495 ambiguous 0.2783 benign -0.317 Destabilizing 1.0 D 0.707 prob.neutral N 0.477795587 None None I
L/Q 0.139 likely_benign 0.1296 benign -0.326 Destabilizing 1.0 D 0.701 prob.neutral N 0.480480928 None None I
L/R 0.2033 likely_benign 0.183 benign 0.217 Stabilizing 1.0 D 0.723 prob.delet. N 0.475506147 None None I
L/S 0.2404 likely_benign 0.2441 benign -0.559 Destabilizing 1.0 D 0.725 prob.delet. None None None None I
L/T 0.2151 likely_benign 0.2133 benign -0.543 Destabilizing 1.0 D 0.729 prob.delet. None None None None I
L/V 0.0986 likely_benign 0.1013 benign -0.317 Destabilizing 0.999 D 0.615 neutral N 0.469802981 None None I
L/W 0.3267 likely_benign 0.3403 ambiguous -0.585 Destabilizing 1.0 D 0.729 prob.delet. None None None None I
L/Y 0.3975 ambiguous 0.4015 ambiguous -0.335 Destabilizing 1.0 D 0.711 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.